Latest rheumatoid arthritis News | Page 2

Harnessing healing power within our cells
Workplace dust and fumes may increase risk of rheumatoid arthritis
Nerve block for knee pain relief
Rogue immune cells linked to leukaemia are key driver of a
Big data used to identify existing drugs that could be repurposed for broader medical applications
Findings support repurposing rheumatoid arthritis drug auranofin for diabetes
Even mild COVID raises chance of heart attack and stroke
Can supplements or diet reduce symptoms of arthritis?
What Autoimmune Diseases Are and What Can Be Done to Alleviate Them
Finding triggers of inflammation
Interrupting treatment of vulnerable people on immune-suppressing medicines
Overlooked, undervalued: Cornell research seeks to elevate home care workers
Lupus-causing gene paves way for new and tailored treatments
AstraZeneca’s antibody combination, Evusheld▼ authorised for use
Studies reveal new mechanisms of arthritis caused by mosquito-borne viruses
Qld dust disease legal expert wins national Civil Justice Award
Life-saving medicines unaffordable as PBS co-pay heads to $50 script
Funding for immunocompromised Covid booster trial
Shortage of abatacept medicines
Study profiles side-effects linked to common immunosuppressant
WHO recommends two new drugs to treat Covid
Machine learning illuminates genetic links between blood cells and disease
ADRF: Expanding research parameters and introducing greater innovation
Evusheld long-acting antibody combination authorised for emergency use
Health impact of coronary heart disease decreases, but still has highest disease burden for Australians
ASIC sues MLC Life Insurance for multiple insurance failures
ASIC sues MLC for multiple insurance failures
New analyses of two AZD7442 Covid Phase III trials in high-risk populations confirm robust efficacy and long-term prevention
Individual fined $18,648 for alleged advertising breaches relating to medicinal cannabis products
Invigorate Labs fined $18,648 for alleged advertising breaches relating to medicinal cannabis
Scientists progress groundbreaking electroceutical research
Funding boost for big Ideas
New therapeutic target pinpointed for stomach cancer
Schizophrenia may be similar to immune disorders, show scientists
Study to determine cyclosporine’s role in treating hospitalized COVID-19 patients
Baricitinib treatment linked to reduced mortality in COVID-19 patients
Cancer treatment could be replicated for COVID-19
New committee members to advise City on access and inclusion
Immune Protein IL-17A Responsible for Lethal Side Effects of Gastric Cancer
International project seeks to improve cancer-fighting therapeutics
TGI initiates a randomised Control trial of Hydroxychloroquine for Health Care Workers exposed to COVID
RACGP reiterates warning on hydroxychloroquine
Christchurch researchers secure lion’s share of almost $1million in funding
Why you shouldn’t go looking for COVID-19 medicines
Approved drug reduces ventilator time for patients with severe COVID
Seizures of medications linked to pandemic on rise
Gene variations at birth
Drug target for aggressive breast cancer found